Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis.
Baek, William S
Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry Jul 2007 - 771 p. digital
Publication Type: Letter
1468-330X
10.1136/jnnp.2006.093567 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Humans
Male
Myasthenia Gravis--drug therapy
Receptor Protein-Tyrosine Kinases--analysis
Receptors, Cholinergic--analysis
Rituximab
Treatment Outcome
Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry Jul 2007 - 771 p. digital
Publication Type: Letter
1468-330X
10.1136/jnnp.2006.093567 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Humans
Male
Myasthenia Gravis--drug therapy
Receptor Protein-Tyrosine Kinases--analysis
Receptors, Cholinergic--analysis
Rituximab
Treatment Outcome